Evangelio, Larry A.
HRN: 26-68-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
MUPIROCIN 2%, 15G (TUBE)
02/12/2025
02/19/2025
TOPICAL
2%
BID
Multiple Abrasion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes